Peter Zandstra continued his research training as a postdoctoral fellow in the field of bioengineering at the Massachusetts Institute of Technology before being appointed to the University of Toronto in 1999.
16 Facts About Peter Zandstra
In 2007, Peter Zandstra was appointed as a professor at the University of Toronto's Institute of Biomaterials and Biomedical Engineering.
Peter Zandstra was cross appointed with the Departments of Chemical Engineering and Applied Chemistry and Medical Genetics.
In 2016, Peter Zandstra became a professor at the University of British Columbia.
Peter Zandstra served as the Founding Director of the School of Biomedical Engineering at the University of British Columbia and was the director of the Michael Smith Laboratories until July 2022.
Peter Zandstra serves on the advisory board of the Phil and Penny Knight Campus for Accelerating Scientific Impact of the University of Oregon and serves as Chief Scientist at the Creative Destruction Lab.
Peter Zandstra is a Chief Scientific Officer at the Centre for Commercialization of Regenerative Medicine and is a part of the Silver Creek Pharmaceuticals team.
Research in the Peter Zandstra Laboratory is focused on the regeneration of functional tissues from stem cells, and the development and utilization of tools to modulate the responses of stem cells in vitro and in vivo.
Peter Zandstra's group is particularly interested in understanding the role that the extracellular environment, the stem cell niche, plays in controlling stem cell fate decisions.
The Peter Zandstra lab focuses in particular on understanding how to grow human blood stem cells, and on understanding how to differentiate pluripotent stem cells into functional blood, cardiac, and pancreatic tissue.
Peter Zandstra currently serves as associate editor for the journals Stem Cells, Stem Cell Research and Biotechnology and Bioengineering.
Peter Zandstra helped with the founding of the IBBME teaching laboratory, designing and implementing more than 6 labs.
Peter Zandstra currently serves as the director of the University of Toronto's Minor in Bioengineering, an engineering faculty-wide program designed to give undergraduate students a co-ordained series of courses in bioengineering related topics.
In 2008, during an annual conference held by the American Association for the Advancement of Science, Peter Zandstra was inducted as its Fellow.
In 2014, Peter Zandstra was elected as a Fellow of the Royal Society of Canada and a year later he was recognized for contributions to development and commercialization of stem cell-based therapies and became a recipient of the Scale-Up and Manufacturing of Cell-Based Therapies Award.
In 2017, Peter Zandstra was appointed as Canada Research Chair in Stem Cell Bioengineering.